📰 3 sources covering this story

STAT+: Eli Lilly targets booming black market for retatrutide

First covered 1 days ago · latest take 54 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

STAT+: Eli Lilly targets booming black market for retatrutide
STAT News
STAT News54 mins ago
STAT+: Eli Lilly targets booming black market for retatrutide
Khartis raises oral immunology funds, Neurocrine drug safety concerns, and more biotech news from The Readout
The Hill
The Hill23 hrs ago
Eli Lilly targets alleged black market sales of its experimental GLP-1 drug
Eli Lilly is suing six entitles that it alleges are selling black market versions of its experimental weight loss drug retatrutide.  Lilly’s lawsuits target U.S. entities selling illegal retatrutide products, including compounding pharmacies, medical spas and online sellers that sell retatrutide as a weight-loss “hack.
Reuters
Reuters🏁 first to report1 days ago
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide  Reuters
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →